Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma
NCT03380468
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
300
Enrollment
OTHER
Sponsor class
Conditions
Lung Neoplasms
Interventions
DRUG:
cisplatin plus pemetrexed
Sponsor
Fudan University